The Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exendin-4 Reduces Cocaine Self-Administration in Mice

Glucagon-like peptide 1 (GLP-1) analogues are used for the treatment of type 2 diabetes. The ability of the GLP-1 system to decrease food intake in rodents has been well described and parallels results from clinical trials. GLP-1 receptors are expressed in the brain, including within the ventral teg...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Physiol Behav
Autori principali: Sørensen, Gunnar, Reddy, India A., Weikop, Pia, Graham, Devon L., Stanwood, Gregg D., Wortwein, Gitta, Galli, Aurelio, Fink-Jensen, Anders
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4668599/
https://ncbi.nlm.nih.gov/pubmed/26072178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.physbeh.2015.06.013
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi